Skip to main content
OPCH
NASDAQ Industrial Applications And Services

Option Care Health Boosts Share Buyback Program to $1 Billion, Provides Strong 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$32.06
Mkt Cap
$5.089B
52W Low
$23.68
52W High
$35.53
52W Position info
35% above low
Off High info
9.8% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

OPCH sits 35% above its 52-week low of $23.68.

Summary

Option Care Health announced a significant expansion of its share repurchase program to $1 billion, alongside preliminary Q4 and full-year 2025 results and optimistic financial guidance for 2026.


Key Events · Financing and Capital Events · OPCH

  • Share Repurchase Program Expanded

    The Board of Directors approved increasing the 2025 share repurchase authorization from $500 million to $1 billion, adding an additional $500 million in capacity. The total remaining capacity is now $693 million.

  • Preliminary 2025 Financial Results

    The company reported preliminary full-year 2025 net revenue of $5.645 billion to $5.655 billion and Adjusted EBITDA of $469 million to $473 million.

  • Positive 2026 Financial Guidance

    Option Care Health issued preliminary full-year 2026 guidance projecting net revenue of $5.8 billion to $6.0 billion and Adjusted EBITDA of $480 million to $505 million, indicating continued growth despite headwinds.

  • J.P. Morgan Healthcare Conference Presentation

    The company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, with presentation materials furnished as an exhibit.


Analysis · OPCH · Industrial Applications And Services

The substantial increase in Option Care Health's share repurchase authorization to $1 billion, representing a significant portion of its market capitalization, is a strong positive signal of management's confidence in future performance and commitment to returning capital to shareholders. This capital allocation strategy, combined with preliminary 2025 results and optimistic 2026 guidance, suggests a robust financial outlook. While the 2026 guidance includes a headwind from Stelara biosimilars, the projected growth in revenue and Adjusted EBITDA indicates underlying business strength. Investors should view the expanded buyback as a material driver for shareholder value.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 49.5% of the 210 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OPCH was trading at $32.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $23.68 to $35.53. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OPCH - Latest Insights

OPCH
Nov 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $31.79
Real-time Price: $31.68 info
Change: -$0.110 (-0.35%) info
Market Cap: $4.746B info
OPCH
Oct 28, 2026, 4:46 PM EDT
Filing Type: PREM14A
Importance Score:
8
Price at Filing: $31.27
Real-time Price: $31.68 info
Change: +$0.410 (+1%) info
Market Cap: $4.746B info
OPCH
Oct 06, 2026, 8:23 AM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $28.16
Real-time Price: $31.68 info
Change: +$3.52 (+12%) info
Market Cap: $4.746B info
OPCH
Oct 06, 2026, 8:22 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $28.16
Real-time Price: $31.68 info
Change: +$3.52 (+12%) info
Market Cap: $4.746B info
OPCH
Oct 06, 2026, 8:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $28.16
Real-time Price: $31.68 info
Change: +$3.52 (+12%) info
Market Cap: $4.746B info